Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 7 | 2023 | 3445 | 1.400 |
Why?
|
| Lipoproteins | 3 | 2022 | 881 | 1.180 |
Why?
|
| Cardiovascular Diseases | 8 | 2023 | 15142 | 0.650 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 758 | 0.550 |
Why?
|
| Triglycerides | 2 | 2022 | 2453 | 0.540 |
Why?
|
| Secondary Prevention | 1 | 2020 | 1529 | 0.470 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 1125 | 0.450 |
Why?
|
| Primary Prevention | 1 | 2020 | 1167 | 0.440 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 1572 | 0.430 |
Why?
|
| Ventricular Function, Left | 3 | 2023 | 3660 | 0.410 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2021 | 3255 | 0.400 |
Why?
|
| Population Surveillance | 1 | 2021 | 2614 | 0.360 |
Why?
|
| Apolipoprotein C-III | 2 | 2022 | 202 | 0.350 |
Why?
|
| Veterans | 1 | 2023 | 2519 | 0.350 |
Why?
|
| Coronary Vessels | 1 | 2020 | 3106 | 0.330 |
Why?
|
| Heart Ventricles | 1 | 2021 | 3817 | 0.320 |
Why?
|
| Peptide Fragments | 1 | 2021 | 5096 | 0.320 |
Why?
|
| Brain Ischemia | 1 | 2022 | 3264 | 0.310 |
Why?
|
| Calcium | 1 | 2020 | 5755 | 0.290 |
Why?
|
| Blood Pressure | 1 | 2021 | 8551 | 0.260 |
Why?
|
| Heart Failure | 2 | 2023 | 10896 | 0.210 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2023 | 471 | 0.200 |
Why?
|
| Lipoprotein-X | 1 | 2020 | 5 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2021 | 23327 | 0.190 |
Why?
|
| Inflammation | 1 | 2020 | 10629 | 0.190 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6485 | 0.190 |
Why?
|
| Lipid Regulating Agents | 1 | 2020 | 24 | 0.180 |
Why?
|
| Echocardiography, Stress | 1 | 2020 | 131 | 0.170 |
Why?
|
| Stroke | 1 | 2022 | 9975 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 11729 | 0.170 |
Why?
|
| Hypertriglyceridemia | 1 | 2020 | 295 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2021 | 1154 | 0.140 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2021 | 375 | 0.140 |
Why?
|
| Risk Factors | 7 | 2021 | 72252 | 0.140 |
Why?
|
| Electric Countershock | 1 | 2019 | 534 | 0.140 |
Why?
|
| Reminder Systems | 1 | 2019 | 371 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2020 | 581 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2020 | 851 | 0.110 |
Why?
|
| RNA Interference | 1 | 2020 | 2890 | 0.100 |
Why?
|
| Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
| Monocytes | 1 | 2020 | 2593 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1542 | 0.090 |
Why?
|
| Stroke Volume | 2 | 2023 | 5002 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1668 | 0.090 |
Why?
|
| Humans | 16 | 2023 | 743811 | 0.090 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 1439 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2021 | 1796 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2023 | 6078 | 0.080 |
Why?
|
| Middle Aged | 6 | 2022 | 213241 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 2074 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 1911 | 0.070 |
Why?
|
| Male | 8 | 2023 | 349776 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 2428 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5033 | 0.060 |
Why?
|
| Prognosis | 2 | 2023 | 29052 | 0.060 |
Why?
|
| Female | 8 | 2023 | 380020 | 0.050 |
Why?
|
| Phenotype | 1 | 2020 | 16361 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 57744 | 0.050 |
Why?
|
| Incidence | 1 | 2021 | 20948 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4467 | 0.050 |
Why?
|
| Aged | 4 | 2023 | 163178 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15518 | 0.050 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2021 | 199 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 53250 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39001 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 40038 | 0.040 |
Why?
|
| United States | 3 | 2021 | 69859 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2019 | 613 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 674 | 0.040 |
Why?
|
| HIV Infections | 1 | 2020 | 16715 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 1151 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 213889 | 0.020 |
Why?
|
| Cause of Death | 1 | 2019 | 3580 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2021 | 3439 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10380 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3530 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12020 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 18355 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77410 | 0.010 |
Why?
|
| Hypertension | 1 | 2021 | 8480 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40545 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85729 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56392 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63042 | 0.010 |
Why?
|
Concepts
(85)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_